Mission Statement

 

Research at the Division of Pharmacology and Toxicology is driven by the motivation to decipher the dynamic mechanisms underlying aging and disease, such as chronic pain. To this end, we combine a diverse set of methods ranging from molecular biology and biochemistry,  electrophysiology,  primary cell culture and preclinical mouse models to molecular modelling and quantitative proteomics. Our goal is to identify novel therapeutic targets that have the potential to improve current treatments of studied diseases.


 News

17.01.2025
 

Our PhD student, Sabrina Grundtner, published a study with the title “Deep proteomics and network pharmacology reveal sex- and age-shared neuropathic...

10.12.2024
 

Chronic Pain, the Functional Microbiome and the Metaproteome in Health and Disease

10.12.2024
 

Dr. Daniel Cuervo-Zanatta was awarded one of the 18 grants (out of about 900 applicants) provided in 2024 by the Secretary of Education, Science,...

09.12.2024
 

Our PhD student Hari Baskar Balasubramanian (PI Zille) was awarded the prestigious Austrian Academy of Sciences (ÖAW) DOC Fellowship 2024 for his PhD...

18.10.2024
 

New article published in British Journal of Pharmacology with contribution from Assoc.-Prof. Dr. Anna Weinzinger:

Development of new Kir2.1 channel...

03.10.2024
 

Unraveling the protein post-translational modification landscape: Neuroinflammation and neuronal death after stroke